Intermittent fasting is better for fat loss

In most trials that compare them directly, intermittent fasting produces about the same weight and fat loss as eating less every day. The most recent Cochrane review pooled 21 trials in 1,430 adults with overweight or obesity, each following people for at least six months, and found that intermittent fasting and regular dietary advice, such as a daily calorie target, differed by a third of a percentage point of starting weight, which the reviewers rated low certainty and described as little to no difference. Compared with making no change, fasting groups lost about 3.4 percent more of their starting weight.

Where fasting has come out ahead, the margin has been modest and tied to particular patterns. A 2025 analysis of 99 trials found alternate-day fasting took off about 1.3 kg more than daily calorie restriction, an advantage seen in trials shorter than six months; across the 17 trials lasting six months or longer, no fasting pattern outperformed daily calorie restriction. Time-restricted eating, such as eating within an eight-hour window, and whole-day fasting, such as the 5:2 approach, did not outperform it. A year-long trial in adults without diabetes, published after that analysis, found that fasting three days a week took off 2.9 kg more than a daily calorie target set to match it (Catenacci 2025). For people taking a sulfonylurea such as glipizide for type 2 diabetes, the drug's US prescribing information states that low blood sugar is more likely when calorie intake is deficient.

Fat mass follows the same pattern. A 2024 review of 28 trials in apparently healthy adults found no significant difference between intermittent and daily calorie restriction in weight (0.42 kg) or fat mass (0.31 kg). The fasting groups lost slightly more fat-free mass, which includes muscle (0.20 kg), and slightly more from the waist (0.9 cm). Within that review, the time-restricted eating trials lost more weight, fat and fat-free mass than daily restriction. The two groups ate comparable amounts in 17 of the 28 trials, the fasting group ate less in 5, and intake was not reported in 6, which the reviewers name as a possible influence on the results. A separate analysis pooled 24 trials lasting six months or longer in 2,032 adults with overweight or obesity. Where those trials compared fasting with daily calorie restriction, fasting groups lost 0.7 kg more fat, with no significant difference in body weight, and the authors describe the two approaches as comparably effective (Khalafi 2025).

A 2025 review of 15 trials lasting a year or longer found that only one of those comparing fasting with daily calorie restriction showed more weight loss with fasting (Vlastaridou 2025). Three of those year-long trials show how this plays out. In China, 139 adults with obesity were all given the same daily calorie target, and half also ate only between 8 a.m. and 4 p.m.; after 12 months they had lost 8.0 kg and 6.3 kg, a 1.8 kg gap that was not statistically significant, and body fat and lean mass did not differ significantly either (Liu 2022). In Chicago, 100 adults were assigned to alternate-day fasting, daily calorie restriction or no change for a year. Relative to the no-change group, the fasting group lost 6.0 percent of its weight and the calorie restriction group 5.3 percent. More people dropped out of alternate-day fasting (38 percent against 29 percent), fasting-day intake ran above the prescribed amount, and LDL cholesterol was 11.5 mg/dL higher at 12 months with fasting than with daily restriction (Trepanowski 2017).

The third, and the largest of the three, is the trial in which fasting came out ahead. In Denver, 165 adults with overweight or obesity either ate about 80 percent less on three days a week and without restriction on the other four, or cut 34 percent every day, the same reduction across the week, and both groups received the same group support and exercise advice. After 12 months the fasting group had lost 7.6 percent of its weight and the daily group 5.0 percent, a difference of 2.9 kg (95% CI 0.1 to 5.7). Fat mass fell 2.1 kg more with fasting, a difference whose range reached zero, and lean mass fell 1.2 kg more. When calorie intake was measured objectively, the fasting group had cut more than the daily group, and fewer people dropped out of fasting (19 percent against 30 percent). The trial excluded people with diabetes, cardiovascular disease or a history of eating disorders (Catenacci 2025). In Australia, 250 night shift workers with overweight or obesity were assigned to two low-calorie days a week or to daily calorie restriction for 24 weeks. Weight at the end differed by less than 1 kg between the fasting groups and the daily group, with wide ranges, and about a third of participants did not provide a final weight (Bonham 2025). The same trial weighed participants again at 18 months, after a year with limited dietitian contact and no study food: weight and fat mass still did not differ between either fasting group and the daily group, and all three groups remained below their starting weight, by 4.8 kg with daily restriction and by 4.5 kg and 3.2 kg in the two fasting groups. 141 of 248 participants provided an 18-month weight, and the authors note the trial may have been too small to detect small differences (Davis 2026).

Fasting is proposed to add something beyond eating less, through the timing of meals against the body's daily clock and greater use of stored fat. In mice fed a high-fat diet, limiting eating to eight hours a day prevented obesity even though they ate the same calories as mice with round-the-clock access (Hatori 2012). In the human trials here that set similar calorie targets for both groups, fasting usually produced no more fat loss, and in the year-long trial where it produced more, the fasting group had also cut more calories when intake was measured. The UK's 2025 obesity guideline makes no recommendation on intermittent fasting: its committee found the evidence showed improvement for a few outcomes but not for most, noted problems with the studies, and called for better trials, including on the side effects of different diets. The Cochrane review rated its evidence on side effects as very uncertain. Neither 2025 trial reported a serious adverse event related to its diets, and both excluded people with diabetes. No source here reports results for pregnancy, adolescents or people with a history of eating disorders.